1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > 2015 Market Research Report on Global Biologics and Biosimilars Industry

Summary

2015 Market Research Report on Global Biologics and Biosimilars Industryis a professional and depth research report on Global Biologics and Biosimilars industry

For overview analysis, the report introduces Biologics and Biosimilars basic information including definition, classification, application, industry chain structure, industry overview, policy analysis, and news analysis, etc

For international and China market analysis, the report analyzes Biologics and Biosimilars markets in China and other countries or regions (such as US, Europe, Japan, etc) by presenting research on global products of different types and applications developments and trends of market, technology, and competitive landscape, and leading suppliers and countries’2009-2014 capacity, production, cost, price, profit, production value, and gross margin. For leading suppliers, related information is listed as products, customers, application, capacity, market position, and company contact information, etc. 2015-2020 forecast on capacity, production, cost, price, profit, production value, and gross margin for these markets are also included.

For technical data and manufacturing plants analysis, the report analyzes Biologics and Biosimilars leading suppliers on capacity, commercial production date, manufacturing plants distribution, R&D Status, technology sources, and raw materials sources.

This report also presents product specification, manufacturing process, and product cost structure etc. Production is separated by regions, technology and applications. Analysis also covers upstream raw materials, equipment, downstream client survey, marketing channels, industry development trend and proposals.

In the end, the export includes Biologics and Biosimilars new project SWOT analysis, investment feasibility analysis, investment return analysis, and development analysis. In conclusion, it is a deep research report on Global Biologics and Biosimilars industry. Here, we express our thanks for the support and assistance from Biologics and Biosimilars industry chain related technical experts and marketing engineers during Research Team’s survey and interviews.

Table Of Contents

2015 Market Research Report on Global Biologics and Biosimilars Industry
Table of Contents

Chapter One Biologics and Biosimilars Industry Overview
1.1 Biologics and Biosimilars Definition
1.2 Biologics and Biosimilars Classification and Application
1.3 Biologics and Biosimilars Industry Chain Structure
1.4 Biologics and Biosimilars Industry Overview
1.5 Biologics and Biosimilars Industry Policy Analysis
1.6 Biologics and Biosimilars Industry News Analysis

Chapter Two Biologics and Biosimilars International and China Market Analysis
2.1 Biologics and Biosimilars Industry International Market Analysis
2.1.1 Biologics and Biosimilars International Market Development History
2.1.2 Biologics and Biosimilars Product and Technology Developments
2.1.3 Biologics and Biosimilars Competitive Landscape Analysis
2.1.4 Biologics and Biosimilars International Key Countries Development Status
2.1.5 Biologics and Biosimilars International Market Development Trend
2.2 Biologics and Biosimilars Industry China Market Analysis
2.2.1 Biologics and Biosimilars China Market Development History
2.2.2 Biologics and Biosimilars Product and Technology Developments
2.2.3 Biologics and Biosimilars Competitive Landscape Analysis
2.2.4 Biologics and Biosimilars China Key Regions Development Status
2.2.5 Biologics and Biosimilars China Market Development Trend
2.3 Biologics and Biosimilars International and China Market Comparison Analysis

Chapter Three Biologics and Biosimilars Technical Data and Manufacturing Plants Analysis
3.1 2014 Global Key Manufacturers Biologics and Biosimilars Capacity and Commercial Production Date
3.2 2014 Global Key Manufacturers Biologics and Biosimilars Manufacturing Plants Distribution
3.3 2014 Global Key Manufacturers Biologics and Biosimilars RandD Status and Technology Source
3.4 2014 Global Key Manufacturers Biologics and Biosimilars Raw Materials Sources Analysis

Chapter Four Biologics and Biosimilars Production by Regions By Technology By Applications
4.1 2009-2014 Biologics and Biosimilars Production by Regions(Such as US EU China Japan etc)
4.2 2009-2014 Biologics and Biosimilars Production by Technology (key type product)
4.3 2009-2014 Biologics and Biosimilars Production by Applications
4.4 2009-2014 Biologics and Biosimilars Price by key Manufacturers
4.5 2009-2014 US Biologics and Biosimilars Capacity Production Price Cost Production Value Analysis
4.6 2009-2014 EU Biologics and Biosimilars Capacity Production Price Cost Production Value Analysis
4.7 2009-2014 Japan Biologics and Biosimilars Capacity Production Price Cost Production Value Analysis
4.8 2009-2014 China Biologics and Biosimilars Capacity Production Price Cost Production Value Analysis
4.9 2009-2014 US Biologics and Biosimilars Supply Import Export Consumption
4.10 2009-2014 EU Biologics and Biosimilars Supply Import Export Consumption
4.11 2009-2014 Japan Biologics and Biosimilars Supply Import Export Consumption
4.12 2009-2014 China Biologics and Biosimilars Supply Import Export Consumption

Chapter Five Biologics and Biosimilars Manufacturing Process and Cost Structure
5.1 Biologics and Biosimilars Product Specifications
5.2 Biologics and Biosimilars Manufacturing Process Analysis
5.3 Biologics and Biosimilars Cost Structure Analysis
5.4 Biologics and Biosimilars Price Cost Gross Analysis

Chapter Six 2009-2014 Biologics and Biosimilars Productions Supply Sales Demand Market Status and Forecast
6.1 2009-2014 Biologics and Biosimilars Capacity Production Overview
6.2 2009-2014 Biologics and Biosimilars Production Market Share Analysis
6.3 2009-2014 Biologics and Biosimilars Demand Overview
6.4 2009-2014 Biologics and Biosimilars Supply Demand and Shortage
6.5 2009-2014 Biologics and Biosimilars Import Export Consumption
6.6 2009-2014 Biologics and Biosimilars Cost Price Production Value Gross Margin

Chapter Seven Biologics and Biosimilars Key Manufacturers Analysis
7.1 Gilead Sciences
7.1.1 Company Profile
7.1.2 Product Picture and Specification
7.1.3 Capacity Production Price Cost Production Value
7.1.4 Contact Information

7.2 Novo Nordisk
7.2.1 Company Profile
7.2.2 Product Picture and Specification
7.2.3 Capacity Production Price Cost Production Value
7.2.4 Contact Information

7.3 Amgen
7.3.1 Company Profile
7.3.2 Product Picture and Specification
7.3.3 Capacity Production Price Cost Production Value
7.3.4 Contact Information

7.4 Biogen Idec
7.4.1 Company Profile
7.4.2 Product Picture and Specification
7.4.3 Capacity Production Price Cost Production Value
7.4.4 Contact Information

7.5 Celgene
7.5.1 Company Profile
7.5.2 Product Picture and Specification
7.5.3 Capacity Production Price Cost Production Value
7.5.4 Contact Information

7.6 Allergan
7.6.1 Company Profile
7.6.2 Product Picture and Specification
7.6.3 Capacity Production Price Cost Production Value
7.6.4 Contact Information

7.7 Shire
7.7.1 Company Profile
7.7.2 Product Picture and Specification
7.7.3 Capacity Production Price Cost Production Value
7.7.4 Contact Information

7.8 Teva Pharmaceutical
7.8.1 Company Profile
7.8.2 Product Picture and Specification
7.8.3 Capacity Production Price Cost Production Value
7.8.4 Contact Information

7.9 Valeant Pharmaceuticals
7.9.1 Company Profile
7.9.2 Product Picture and Specification
7.9.3 Capacity Production Price Cost Production Value
7.9.4 Contact Information

7.10 Actavis
7.10.1 Company Profile
7.10.2 Product Picture and Specification
7.10.3 Capacity Production Price Cost Production Value
7.10.4 Contact Information

7.11 Alexion Pharmaceuticals
7.11.1 Company Profile
7.11.2 Product Picture and Specification
7.11.3 Capacity Production Price Cost Production Value
7.11.4 Contact Information

7.12 Regeneron Pharmaceuticals
7.12.1 Company Profile
7.12.2 Product Picture and Specification
7.12.3 Capacity Production Price Cost Production Value
7.12.4 Contact Information

7.13 CSL
7.13.1 Company Profile
7.13.2 Product Picture and Specification
7.13.3 Capacity Production Price Cost Production Value
7.13.4 Contact Information

7.14 Sun Pharmaceutical
7.14.1 Company Profile
7.14.2 Product Picture and Specification
7.14.3 Capacity Production Price Cost Production Value
7.14.4 Contact Information

7.15 Merck KGaA
7.15.1 Company Profile
7.15.2 Product Picture and Specification
7.15.3 Capacity Production Price Cost Production Value
7.15.4 Contact Information

7.16 Vertex Pharmaceuticals
7.16.1 Company Profile
7.16.2 Product Picture and Specification
7.16.3 Capacity Production Price Cost Production Value
7.16.4 Contact Information

7.17 UCB
7.17.1 Company Profile
7.17.2 Product Picture and Specification
7.17.3 Capacity Production Price Cost Production Value
7.17.4 Contact Information

7.18 Actelion
7.18.1 Company Profile
7.18.2 Product Picture and Specification
7.18.3 Capacity Production Price Cost Production Value
7.18.4 Contact Information

7.19 Endo International
7.19.1 Company Profile
7.19.2 Product Picture and Specification
7.19.3 Capacity Production Price Cost Production Value
7.19.4 Contact Information

7.20 BioMarin Pharmaceutical
7.20.1 Company Profile
7.20.2 Product Picture and Specification
7.20.3 Capacity Production Price Cost Production Value
7.20.4 Contact Information

7.21 Jazz Pharmaceuticals
7.21.1 Company Profile
7.21.2 Product Picture and Specification
7.21.3 Capacity Production Price Cost Production Value
7.21.4 Contact Information

7.22 Salix Pharmaceuticals
7.22.1 Company Profile
7.22.2 Product Picture and Specification
7.22.3 Capacity Production Price Cost Production Value
7.22.4 Contact Information

7.23 Sinopharm Group
7.23.1 Company Profile
7.23.2 Product Picture and Specification
7.23.3 Capacity Production Price Cost Production Value
7.23.4 Contact Information

7.24 Pharmacyclics
7.24.1 Company Profile
7.24.2 Product Picture and Specification
7.24.3 Capacity Production Price Cost Production Value
7.24.4 Contact Information

7.25 Dr. Reddy's Laboratories
7.25.1 Company Profile
7.25.2 Product Picture and Specification
7.25.3 Capacity Production Price Cost Production Value
7.25.4 Contact Information

Chapter Eight Up and Down Stream Industry Analysis
8.1 Upstream Raw Materials Suppliers and Price Analysis
8.2 Processing Equipments and Suppliers Analysis
8.3 Key Applications and Consumption Analysis
8.4 Key Regions and Consumption Analysis

Chapter Nine Biologics and Biosimilars Marketing Channels Analysis
9.1 Biologics and Biosimilars Marketing Channels Status
9.2 Biologics and Biosimilars Marketing Channels Characteristic
9.3 Biologics and Biosimilars Marketing Channels Development Trend
9.4 Biologics and Biosimilars Global Key Distributors Analysis

Chapter Ten 2015-2020 Biologics and Biosimilars Industry Development Trend
10.1 2015-2020 Biologics and Biosimilars Capacity Production Overview
10.2 2015-2020 Biologics and Biosimilars Production Market Share Analysis
10.3 2015-2020 Biologics and Biosimilars Demand Overview
10.4 2015-2020 Biologics and Biosimilars Supply Demand and Shortage
10.5 2015-2020 Biologics and Biosimilars Import Export Consumption
10.6 2015-2020 Biologics and Biosimilars Cost Price Production Value Gross Margin

Chapter Eleven Biologics and Biosimilars Supply Chain Relationship Analysis
11.1 Raw Materials Major Suppliers and Contact Information
11.2 Manufacturing Equipments Suppliers and Contact Information
11.3 Biologics and Biosimilars Major Suppliers and Contact Information
11.4 Key Consumers and Their Contact Information
11.5 Biologics and Biosimilars Supply Chain Relationship Analysis

Chapter Twelve Biologics and Biosimilars New Project Investment Feasibility Analysis
12.1 Biologics and Biosimilars Project SWOT Analysis
12.2 Biologics and Biosimilars New Project Investment Feasibility Analysis

Chapter Thirteen Global Biologics and Biosimilars Industry Research Conclusions


Tables and Figures

Figure Biologics and Biosimilars product picture
Table Biologics and Biosimilars Classification and Application
Figure Biologics and Biosimilars Industry Chain Structure
Table Global Main Biologics and Biosimilars manufacturer list
Table Biologics and Biosimilars Industry Policy List
Table Biologics and Biosimilars Industry News List
Figure Biologics and Biosimilars International Market Development History
Figure 2014 Global Major Manufacturers Biologics and Biosimilars Production Market Share
Figure 2014 Global Major Countries Biologics and Biosimilars Production Market Share
Figure 2015-2020 Global Biologics and Biosimilars Capacity Production and Growth Rate
Figure Biologics and Biosimilars China Market Development History
Figure 2014 China Major Manufacturers Biologics and Biosimilars Production Market Share
Figure 2014 China Key Regions Biologics and Biosimilars Production Market Share
Figure 2015-2020 China Biologics and Biosimilars Capacity Production and Growth Rate
Figure Biologics and Biosimilars International and China Market Comparison
Table 2014 Global and China Key Manufacturers Biologics and Biosimilars Product Line Capacity and Commercial Production Date
Table 2014 Manufacturing Base (Factory) Global Regional Distribution
Table 2014 Global and China Key Manufacturers Biologics and Biosimilars RandD Status and Technology Sources List
Table 2014 Global and China Key Manufacturers Biologics and Biosimilars Raw Materials Sources List
Table 2009-2014 Biologics and Biosimilars Production (K Unit) by Regions
Figure 2009 Global Biologics and Biosimilars Production market share by regions
Figure 2010 Global Biologics and Biosimilars Production market share by regions
Figure 2011 Global Biologics and Biosimilars Production market share by regions
Figure 2012 Global Biologics and Biosimilars Production market share by regions
Figure 2013 Global Biologics and Biosimilars Production market share by regions
Figure 2014 Global Biologics and Biosimilars Production market share by regions
Figure 2009 Biologics and Biosimilars Production market share by Technology
Figure 2014 Global Biologics and Biosimilars Production market share by Technology
Table 2009-2014 Biologics and Biosimilars Production market share by Applications
Figure 2014 Global Biologics and Biosimilars Production market share by Applications
Figure 2014 Biologics and Biosimilars Price by key Manufacturers
Table US Biologics and Biosimilars Capacity Production Price Cost Production Value
Table EU Biologics and Biosimilars Capacity Production Price Cost Production Value
Table Japan Biologics and Biosimilars Capacity Production Price Cost Production Value
Table China Biologics and Biosimilars Capacity Production Price Cost Production Value
Table 2009-2014 US Biologics and Biosimilars Supply Import Export Consumption
Table 2009-2014 EU Biologics and Biosimilars Supply Import Export Consumption
Table 2009-2014 Japan Biologics and Biosimilars Supply Import Export Consumption
Table 2009-2014 China Biologics and Biosimilars Supply Import Export Consumption
Table Biologics and Biosimilars Product Details
Table Biologics and Biosimilars Product Specifications List
Figure Biologics and Biosimilars Manufacturing Process
Table 2014 Biologics and Biosimilars Cost Structure Analysis
Table 2009-2014 Global Major Manufacturers Biologics and Biosimilars Capacity and Total Capacity (K Unit) List
Table 2009-2014 Global Major Manufacturers Biologics and Biosimilars Capacity Market Share List
Table 2009-2014 Global Major Manufacturers Biologics and Biosimilars Production and Total Production (K Unit) List
Table 2009-2014 Global Major Manufacturers Biologics and Biosimilars Production Market Share List
Figure 2009-2014 Global Biologics and Biosimilars Capacity Production (K Unit) and Growth Rate
Table 2009-2014 Global Biologics and Biosimilars Capacity Utilization Rate List
Table 2009-2014 China Major Manufacturers Biologics and Biosimilars Capacity and Total Capacity (K Unit) List
Table 2009-2014 China Major Manufacturers Biologics and Biosimilars Capacity Market Share List
Table 2009-2014 China Major Manufacturers Biologics and Biosimilars Production and Total Production (K Unit) List
Table 2009-2014 China Major Manufacturers Biologics and Biosimilars Production Market Share List
Figure 2009-2014 China Biologics and Biosimilars Capacity Production (K Unit) and Growth Rate
Figure 2009 Global Major Manufacturers Biologics and Biosimilars Production Market Share
Figure 2010 Global Major Manufacturers Biologics and Biosimilars Production Market Share
Figure 2011 Global Major Manufacturers Biologics and Biosimilars Production Market Share
Figure 2012 Global Major Manufacturers Biologics and Biosimilars Production Market Share
Figure 2013 Global Major Manufacturers Biologics and Biosimilars Production Market Share
Figure 2014 Global Major Manufacturers Biologics and Biosimilars Production Market Share
Figure 2009 China Major Manufacturers Biologics and Biosimilars Production Market Share
Figure 2010 China Major Manufacturers Biologics and Biosimilars Production Market Share
Figure 2011 China Major Manufacturers Biologics and Biosimilars Production Market Share
Figure 2012 China Major Manufacturers Biologics and Biosimilars Production Market Share
Figure 2013 China Major Manufacturers Biologics and Biosimilars Production Market Share
Figure 2014 China Major Manufacturers Biologics and Biosimilars Production Market Share
Figure 2009-2014 Global Biologics and Biosimilars Demand (K Unit) and Growth Rate
Figure 2009-2014 China Biologics and Biosimilars Demand (K Unit) and Growth Rate
Table 2009-2014 Global Biologics and Biosimilars Supply Demand Shortage (K Unit) List
Table 2009-2014 China Biologics and Biosimilars Supply Demand Shortage (K Unit) List
Table 2009-2014 China Biologics and Biosimilars Production Import Export Consumption (K Unit) List
Table 2009-2014 Global Major Manufacturers Biologics and Biosimilars Price (USD/Unit) List
Table 2009-2014 Global Major Manufacturers Biologics and Biosimilars Gross Margin List
Table 2009-2014 Global Major Manufacturers Biologics and Biosimilars Production Value (Million USD) List
Table 2009-2014 Global Major Manufacturers Biologics and Biosimilars Production Value market share List
Table 2009-2014 China Major Manufacturers Biologics and Biosimilars Production Value (Million USD) List
Table 2009-2014 China Major Manufacturers Biologics and Biosimilars Production Value market share List
Table 2009-2014 Global Biologics and Biosimilars Production (K Unit) Price Cost Profit (USD/Unit) Production Value (Million USD) Gross Margin List
Table 2009-2014 China Biologics and Biosimilars Production (K Unit) Price Cost Profit (USD/Unit) Production Value (Million USD) Gross Margin List
Table 2009-2014 Gilead Sciences Biologics and Biosimilars Product Capacity Production (K Unit) Price Cost Gross (USD/Unit) Production Value (Million USD) Gross Margin List
Figure 2009-2014 Gilead Sciences Biologics and Biosimilars Product Capacity Production (K Unit) and Growth Rate
Figure 2009-2014 Gilead Sciences Biologics and Biosimilars Product Production Global Market Share
Table 2009-2014 Novo Nordisk Biologics and Biosimilars Product Capacity Production (K Unit) Price Cost Gross (USD/Unit) Production Value (Million USD) Gross Margin List
Figure 2009-2014 Novo Nordisk Biologics and Biosimilars Product Capacity Production (K Unit) and Growth Rate
Figure 2009-2014 Novo Nordisk Biologics and Biosimilars Product Production Global Market Share
Table 2009-2014 Amgen Biologics and Biosimilars Product Capacity Production (K Unit) Price Cost Gross (USD/Unit) Production Value (Million USD) Gross Margin List
Figure 2009-2014 Amgen Biologics and Biosimilars Product Capacity Production (K Unit) and Growth Rate
Figure 2009-2014 Amgen Biologics and Biosimilars Product Production Global Market Share
Table 2009-2014 Biogen Idec Biologics and Biosimilars Product Capacity Production (K Unit) Price Cost Gross (USD/Unit) Production Value (Million USD) Gross Margin List
Figure 2009-2014 Biogen Idec Biologics and Biosimilars Product Capacity Production (K Unit) and Growth Rate
Figure 2009-2014 Biogen Idec Biologics and Biosimilars Product Production Global Market Share
Table 2009-2014 Celgene Biologics and Biosimilars Product Capacity Production (K Unit) Price Cost Gross (USD/Unit) Production Value (Million USD) Gross Margin List
Figure 2009-2014 Celgene Biologics and Biosimilars Product Capacity Production (K Unit) and Growth Rate
Figure 2009-2014 Celgene Biologics and Biosimilars Product Production Global Market Share
Table 2009-2014 Allergan Biologics and Biosimilars Product Capacity Production (K Unit) Price Cost Gross (USD/Unit) Production Value (Million USD) Gross Margin List
Figure 2009-2014 Allergan Biologics and Biosimilars Product Capacity Production (K Unit) and Growth Rate
Figure 2009-2014 Allergan Biologics and Biosimilars Product Production Global Market Share
Table 2009-2014 Shire Biologics and Biosimilars Product Capacity Production (K Unit) Price Cost Gross (USD/Unit) Production Value (Million USD) Gross Margin List
Figure 2009-2014 Shire Biologics and Biosimilars Product Capacity Production (K Unit) and Growth Rate
Figure 2009-2014 Shire Biologics and Biosimilars Product Production Global Market Share
Table 2009-2014 Teva Pharmaceutical Biologics and Biosimilars Product Capacity Production (K Unit) Price Cost Gross (USD/Unit) Production Value (Million USD) Gross Margin List
Figure 2009-2014 Teva Pharmaceutical Biologics and Biosimilars Product Capacity Production (K Unit) and Growth Rate
Figure 2009-2014 Teva Pharmaceutical Biologics and Biosimilars Product Production Global Market Share
Table 2009-2014 Valeant Pharmaceuticals Biologics and Biosimilars Product Capacity Production (K Unit) Price Cost Gross (USD/Unit) Production Value (Million USD) Gross Margin List
Figure 2009-2014 Valeant Pharmaceuticals Biologics and Biosimilars Product Capacity Production (K Unit) and Growth Rate
Figure 2009-2014 Valeant Pharmaceuticals Biologics and Biosimilars Product Production Global Market Share
Table 2009-2014 Actavis Biologics and Biosimilars Product Capacity Production (K Unit) Price Cost Gross (USD/Unit) Production Value (Million USD) Gross Margin List
Figure 2009-2014 Actavis Biologics and Biosimilars Product Capacity Production (K Unit) and Growth Rate
Figure 2009-2014 Actavis Biologics and Biosimilars Product Production Global Market Share
Table 2009-2014 Alexion Pharmaceuticals Biologics and Biosimilars Product Capacity Production (K Unit) Price Cost Gross (USD/Unit) Production Value (Million USD) Gross Margin List
Figure 2009-2014 Alexion Pharmaceuticals Biologics and Biosimilars Product Capacity Production (K Unit) and Growth Rate
Figure 2009-2014 Alexion Pharmaceuticals Biologics and Biosimilars Product Production Global Market Share
Table 2009-2014 Regeneron Pharmaceuticals Biologics and Biosimilars Product Capacity Production (K Unit) Price Cost Gross (USD/Unit) Production Value (Million USD) Gross Margin List
Figure 2009-2014 Regeneron Pharmaceuticals Biologics and Biosimilars Product Capacity Production (K Unit) and Growth Rate
Figure 2009-2014 Regeneron Pharmaceuticals Biologics and Biosimilars Product Production Global Market Share
Table 2009-2014 CSL Biologics and Biosimilars Product Capacity Production (K Unit) Price Cost Gross (USD/Unit) Production Value (Million USD) Gross Margin List
Figure 2009-2014 CSL Biologics and Biosimilars Product Capacity Production (K Unit) and Growth Rate
Figure 2009-2014 CSL Biologics and Biosimilars Product Production Global Market Share
Table 2009-2014 Sun Pharmaceutical Biologics and Biosimilars Product Capacity Production (K Unit) Price Cost Gross (USD/Unit) Production Value (Million USD) Gross Margin List
Figure 2009-2014 Sun Pharmaceutical Biologics and Biosimilars Product Capacity Production (K Unit) and Growth Rate
Figure 2009-2014 Sun Pharmaceutical Biologics and Biosimilars Product Production Global Market Share
Table 2009-2014 Merck KGaA Biologics and Biosimilars Product Capacity Production (K Unit) Price Cost Gross (USD/Unit) Production Value (Million USD) Gross Margin List
Figure 2009-2014 Merck KGaA Biologics and Biosimilars Product Capacity Production (K Unit) and Growth Rate
Figure 2009-2014 Merck KGaA Biologics and Biosimilars Product Production Global Market Share
Table 2009-2014 Vertex Pharmaceuticals Biologics and Biosimilars Product Capacity Production (K Unit) Price Cost Gross (USD/Unit) Production Value (Million USD) Gross Margin List
Figure 2009-2014 Vertex Pharmaceuticals Biologics and Biosimilars Product Capacity Production (K Unit) and Growth Rate
Figure 2009-2014 Vertex Pharmaceuticals Biologics and Biosimilars Product Production Global Market Share
Table 2009-2014 UCB Biologics and Biosimilars Product Capacity Production (K Unit) Price Cost Gross (USD/Unit) Production Value (Million USD) Gross Margin List
Figure 2009-2014 UCB Biologics and Biosimilars Product Capacity Production (K Unit) and Growth Rate
Figure 2009-2014 UCB Biologics and Biosimilars Product Production Global Market Share
Table 2009-2014 Actelion Biologics and Biosimilars Product Capacity Production (K Unit) Price Cost Gross (USD/Unit) Production Value (Million USD) Gross Margin List
Figure 2009-2014 Actelion Biologics and Biosimilars Product Capacity Production (K Unit) and Growth Rate
Figure 2009-2014 Actelion Biologics and Biosimilars Product Production Global Market Share
Table 2009-2014 Endo International Biologics and Biosimilars Product Capacity Production (K Unit) Price Cost Gross (USD/Unit) Production Value (Million USD) Gross Margin List
Figure 2009-2014 Endo International Biologics and Biosimilars Product Capacity Production (K Unit) and Growth Rate
Figure 2009-2014 Endo International Biologics and Biosimilars Product Production Global Market Share
Table 2009-2014 BioMarin Pharmaceutical Biologics and Biosimilars Product Capacity Production (K Unit) Price Cost Gross (USD/Unit) Production Value (Million USD) Gross Margin List
Figure 2009-2014 BioMarin Pharmaceutical Biologics and Biosimilars Product Capacity Production (K Unit) and Growth Rate
Figure 2009-2014 BioMarin Pharmaceutical Biologics and Biosimilars Product Production Global Market Share
Table 2009-2014 Jazz Pharmaceuticals Biologics and Biosimilars Product Capacity Production (K Unit) Price Cost Gross (USD/Unit) Production Value (Million USD) Gross Margin List
Figure 2009-2014 Jazz Pharmaceuticals Biologics and Biosimilars Product Capacity Production (K Unit) and Growth Rate
Figure 2009-2014 Jazz Pharmaceuticals Biologics and Biosimilars Product Production Global Market Share
Table 2009-2014 Salix Pharmaceuticals Biologics and Biosimilars Product Capacity Production (K Unit) Price Cost Gross (USD/Unit) Production Value (Million USD) Gross Margin List
Figure 2009-2014 Salix Pharmaceuticals Biologics and Biosimilars Product Capacity Production (K Unit) and Growth Rate
Figure 2009-2014 Salix Pharmaceuticals Biologics and Biosimilars Product Production Global Market Share
Table 2009-2014 Sinopharm Group Biologics and Biosimilars Product Capacity Production (K Unit) Price Cost Gross (USD/Unit) Production Value (Million USD) Gross Margin List
Figure 2009-2014 Sinopharm Group Biologics and Biosimilars Product Capacity Production (K Unit) and Growth Rate
Figure 2009-2014 Sinopharm Group Biologics and Biosimilars Product Production Global Market Share
Table 2009-2014 Pharmacyclics Biologics and Biosimilars Product Capacity Production (K Unit) Price Cost Gross (USD/Unit) Production Value (Million USD) Gross Margin List
Figure 2009-2014 Pharmacyclics Biologics and Biosimilars Product Capacity Production (K Unit) and Growth Rate
Figure 2009-2014 Pharmacyclics Biologics and Biosimilars Product Production Global Market Share
Table 2009-2014 Dr. Reddy's Laboratories Biologics and Biosimilars Product Capacity Production (K Unit) Price Cost Gross (USD/Unit) Production Value (Million USD) Gross Margin List
Figure 2009-2014 Dr. Reddy's Laboratories Biologics and Biosimilars Product Capacity Production (K Unit) and Growth Rate
Figure 2009-2014 Dr. Reddy's Laboratories Biologics and Biosimilars Product Production Global Market Share
Figure Upstream Equipment
Figure Biologics and Biosimilars Industry Chain Structure
Figure Biologics and Biosimilars Marketing Channels Status
Figure 2015-2020 Global Biologics and Biosimilars Capacity Production (K Unit) and Growth Rate
Table 2015-2020 Global Biologics and Biosimilars Capacity Utilization Rate List
Figure 2015-2020 China Biologics and Biosimilars Capacity Production (K Unit) and Growth Rate
Table 2015-2020 China Biologics and Biosimilars Capacity Utilization Rate List
Figure 2015-2020 China Major Manufacturers Biologics and Biosimilars Capacity Market Share
Figure 2015-2020 China Major Manufacturers Biologics and Biosimilars Production Market Share
Figure 2015-2020 Global and China Biologics and Biosimilars Demand (K Unit) and Growth Rate
Table 2015-2020 Global Biologics and Biosimilars Supply Demand Shortage (K Unit) List
Table 2015-2020 China Biologics and Biosimilars Supply Demand Shortage (K Unit) List
Table 2015-2020 China Biologics and Biosimilars Production Import Export Consumption (K Unit) List
Table 2015-2020 Global Biologics and Biosimilars Production (K Unit) Price Cost Profit (USD/Unit) Production Value (Million USD) Gross Margin List
Table 2015-2020 China Biologics and Biosimilars Production (K Unit) Price Cost Profit (USD/Unit) Production Value (Million USD) Gross Margin List
Table Macroeconomic Development Countermeasures Analysis
Table Biologics and Biosimilars Raw Materials Major Suppliers and Contact Information List
Table Biologics and Biosimilars Manufacturing Equipments Suppliers and Contact Information List
Table Biologics and Biosimilars Major Suppliers and Contact Information
Table Biologics and Biosimilars Key Consumers and Their Contact Information List
Table Global Biologics and Biosimilars Supply Chain Relationship of Major Suppliers
Table 2014 Biologics and Biosimilars New Project SWOT Analysis
Table Biologics and Biosimilars New Project Investment Return and Feasibility Analysis

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Remicade Biosimilar Market: By Type (Recombinant Non-Glycosylated Protein, Others), By Technology (MAb, rDNA, Others), By Service (Contract Research, CRAMS,Others), By Application (Blood Disorders, Oncology Diseases, Others), By Region-Forecast (2016-2021

Remicade Biosimilar Market: By Type (Recombinant Non-Glycosylated Protein, Others), By Technology (MAb, rDNA, Others), By Service (Contract Research, CRAMS,Others), By Application (Blood Disorders, Oncology Diseases, Others), By Region-Forecast (2016-2021

  • $ 5250
  • Industry report
  • September 2016
  • by Industry ARC

Globally, development of efficient and advance technology, higher expiration patent, rise in the awareness among people regarding remicade biosimilar, increasing government initiative across the globe, ...

Biosimilar - Global Market Outlook (2016-2022)

Biosimilar - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • September 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Biosimilars market is estimated to be $3.5 billion in 2015 with a CAGR of 23.8% is poised to reach $15.6 billion by 2022. High end adoption of off patented drugs ...

Insulin Biosimilars - Global Market Outlook (2016-2022)

Insulin Biosimilars - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • October 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Insulin Biosimilars market is accounted for $xx million in 2015 and is expected to reach $xx million by 2022 growing at a CAGR of xx% from 2015 to 2022. Growing ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.